PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma

被引：0
作者：
Sang Kyum Kim
Jee Hung Kim
Seung Hyun Kim
Young Han Lee
Jung Woo Han
Wooyeol Baek
Ha Young Woo
Min Kyung Jeon
Hyo Song Kim
机构：
[1] Yonsei University College of Medicine,Department of Pathology
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Department of Orthopedic Surgery
[4] Yonsei University College of Medicine,Department of Radiology
[5] Yonsei University College of Medicine,Division of Pediatric Hemato
[6] Yonsei University College of Medicine,Oncology, Department of Pediatrics
[7] Yonsei University College of Medicine,Department of Plastic Surgery
[8] Yonsei Cancer Center,Division of Medical Oncology, Department of Internal Medicine
[9] Yonsei University College of Medicine,undefined
来源：
BMC Cancer | / 21卷
关键词：
Soft tissue sarcoma; Pazopanib; PD-L1; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Regulation of PD-L1 Expression by Nuclear Receptors
    Kiriyama, Yoshimitsu
    Nochi, Hiromi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [42] PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer
    Schoene, Nadja
    Kemper, Marcel
    Menck, Kerstin
    Evers, Georg
    Krekeler, Carolin
    Schulze, Arik Bernard
    Lenz, Georg
    Wardelmann, Eva
    Binder, Claudia
    Bleckmann, Annalen
    JOURNAL OF EXTRACELLULAR VESICLES, 2024, 13 (03)
  • [43] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [44] PD-L1 Expression as Predictive Biomarker in Patients with NSCLC: A Pooled Analysis
    Passiglia, Francesco
    Bronte, Giuseppe
    Rizzo, Sergio
    Galvano, Antonio
    Sortino, Giovanni
    Musso, Emmanuela
    Listi, Angela
    Barraco, Nadia
    Castiglia, Marta
    Calo, Valentina
    Bazan, Viviana
    Cicero, Giuseppe
    Rolfo, Christian
    Russo, Antonio
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S232 - S233
  • [45] Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: A meta-analysis
    Zhang, Binbin
    Liu, Yi
    Zhou, Sijing
    Jiang, Huihui
    Zhu, Ke
    Wang, Ran
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [46] PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component
    Tanigawa, Masahiko
    Naito, Yoshiki
    Akiba, Jun
    Kawahara, Akihiko
    Okabe, Yoshinobu
    Ishida, Yusuke
    Ishikawa, Hiroto
    Hisaka, Toru
    Fujita, Fumihiko
    Yasunaga, Masafumi
    Shigaki, Takahiro
    Sudo, Tomoya
    Mihara, Yutaro
    Nakayama, Masamichi
    Kondo, Reiichiro
    Kusano, Hironori
    Shimamatsu, Kazuhide
    Okuda, Koji
    Akagi, Yoshito
    Yano, Hirohisa
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (12) : 2069 - 2074
  • [47] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [48] The predictive value and correlation of β-catenin, CMTM6, and PD-L1 expression in colorectal cancer
    Li, Bingquan
    Wu, Shigang
    Qiu, Zhanlong
    Zhong, Xuejun
    Chen, Zhe
    Luo, Feng
    Li, Jinbang
    Liu, Kunping
    NEOPLASMA, 2022, 69 (03) : 691 - 699
  • [49] Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression
    Pyo, Jung-Soo
    Ko, Soo Hee
    Ko, Young San
    Kim, Nae Yu
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (02)
  • [50] Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
    Camilla Christensen
    Lotte K. Kristensen
    Maria Z. Alfsen
    Carsten H. Nielsen
    Andreas Kjaer
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1302 - 1313
12345